The Belgian company is specialised in pharmaceutics, focussing on the development, manufacturing and commercialisation of drugs and/or generic products dedicated to healthcare. The company offers the latest generation, highly flexible, multiform sterile injectables manufacturing platform (vials, ready-to-use cartridges, ready-to-use syringes). It is looking for subcontracting, manufacturing and/or outsourcing agreement in the field of sterile injectables.
The company based in Belgium is specialised in pharmaceutics, focussing on the development, manufacturing and commercialisation of drugs and/or generic products dedicated to healthcare. It offers CDMO (contract development manufacturing organization) support to interested third parties in their development and production of sterile injectables, and is able to manage full drug development from proof of concept to market including manufacturing. The concept of the company's CDMO facility as set out provides the flexibility in terms of products, of forms as well as in terms of processes. Flexibility in terms of products = Diversity of products with high added value : medium speed filling line combined with nested technology = Small to medium batch sizes with optimized line clearances and set-up time = Toxic and non-toxic products Flexibility in terms of forms = All in one filling line for a full range of formats (vials, cartridges and ready-to-use syringes) = Low and high viscous products can be processed (regular and vacuum technology) Flexibility in terms of processes = High security : grade A isolator technology for toxic configuration. Having developed important various production capacities, the industrial company is seeking long-term collaboration, offering its unique know-how and the latest generation, highly flexible, multiform sterile injectables manufacturing platform to partners willing to produce vials, cartridges and ready-to-use syringes. With its solid national reputation, it aims at becoming a key partner at the international level through subcontracting, manufacturing and/or outsourcing agreement. Implementation includes quality systems that allow flexibility for various customer approaches, process knowledge transfer mechanisms between CDMO and the customer and edition of a quality agreement (that captures the elements of validation).
Innovations and advantages
- Nested technology; - Flexible aseptic manufacturing process; - Adaptable to multiple pharmaceutical forms and APIs (active pharmaceutical ingredients - hormones and non hormones); - Small to medium batch sizes; - Extensive quality management system; - High flexibility adapted to the customer needs (production of vials, cartridges and read-to-use syringes on demand); - Shorter processing time compared to other techniques; - Very good price-performance ratio.
06001015 Pharmaceutical Products / Drugs
Market application codes
05007002 Pharmaceuticals/fine chemicals
Area of partner's activity
Industrial partners in the healthcare or pharmaceutical sectors for subcontracting. Industrial partners in the healthcare or pharmaceutical sectors with high potent products dossiers (including hormones) and looking for subcontracting their products into a production platform for complex therapeutical entities.